Emergências e Terapia Intensiva
Revisão | Tratamento multidisciplinar da lesão traqueobrônquica.
4 Fev, 2022 | 14:27hMultidisciplinary management of tracheobronchial injury – European Respiratory Review
FDA interrompe o uso de anticorpos monoclonais que não funcionam contra a Ômicron.
31 Jan, 2022 | 08:56hFDA halts use of antibody drugs that don’t work vs. omicron – Associated Press
Conteúdo relacionado: Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
Diretrizes ELSO para circuitos de oxigenação extracorpórea para pacientes adultos e pediátricos.
31 Jan, 2022 | 08:47hELSO Guidelines for Adult and Pediatric Extracorporeal Membrane Oxygenation Circuits – ASAIO Journal
Conteúdo relacionado: ELSO Guidelines for anticoagulation in adult and pediatric patients using extracorporeal membrane oxygenation (ECMO).
Comentário no Twitter
The new ELSO guidelines, describing #ECMO circuits for all
patient populations, adult and pediatric, are now available, open access on @asaiojournal These consensus guidelines describe safe practice based on extensive experience.
Download full text #FOAMcchttps://t.co/Miu9sbY2gs pic.twitter.com/HU6zCwX031— ELSO (@ELSOOrg) January 28, 2022
Resumo de diretriz | Tratamento dos 10 eventos adversos imunológicos mais comuns em pacientes em imunoterapia.
31 Jan, 2022 | 08:39hArtigo original: ASCO Guideline Update: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy.
Conteúdos relacionados:
Clinical practice guideline on immune checkpoint inhibitor-related adverse events.
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities (várias fontes sobre o tema)
Estudo randomizado | Imunoglobulina hiperimune não melhorou os desfechos de pacientes internados com COVID-19.
28 Jan, 2022 | 17:24hComentários:
Diretrizes ELSO para anticoagulação em pacientes adultos e pediátricos usando oxigenação extracorpórea (extracorporeal membrane oxygenation – ECMO).
28 Jan, 2022 | 16:59h2021 ELSO Adult and Pediatric Anticoagulation Guidelines – ASAIO Journal
Comentário no Twitter
The updated @ELSOOrg adult & pediatric anticoagulation guidelines just out, open access, on @asaiojournal
🩸anticoagulants
🩸therapeutic monitoring of anticoagulants
🩸management of bleeding & thrombotic complications#FOAMcc #FOAMecmo #PedsICU
🖇 https://t.co/sC8iQK6YL0 pic.twitter.com/hkbVoNBDkR— ELSO (@ELSOOrg) January 21, 2022
Diretrizes baseadas em evidências para tratamento pré-hospitalar da dor.
28 Jan, 2022 | 16:58hEstudo randomizado | Controle da hipotensão pós-cirúrgica usando um sistema fechado de infusão de norepinefrina em pacientes submetidos a cirurgia cardíaca.
28 Jan, 2022 | 16:56hControl of Postoperative Hypotension Using a Closed-Loop System for Norepinephrine Infusion in Patients After Cardiac Surgery: A Randomized Trial – Anesthesia & Analgesia (link para o resumo – $ para o texto completo)
Conteúdo relacionado: RCT: Computer-assisted individualized hemodynamic management reduces intraoperative hypotension in intermediate- and high-risk surgery – larger trials with patient-relevant outcomes are required.
Estudo laboratorial mostra que novas pílulas antivirais mantêm sua eficácia contra a variante Ômicron, mas anticorpos monoclonais são substancialmente menos efetivos.
28 Jan, 2022 | 16:28h
Comentário no Twitter
Investigators assessed the in vitro activities of seven monoclonal antibodies & three antiviral drugs against #COVID19 variants. All antibodies showed no or weak neutralizing activity against omicron; two drugs effective at omicron neutralization. https://t.co/rOZzmtsDZS pic.twitter.com/shfKDW6r5q
— NEJM (@NEJM) January 26, 2022
Casos de transplante de pulmão para insuficiência respiratória relacionada a Covid-19 nos EUA foram associados com sobrevida de 3 meses de 95,6%.
28 Jan, 2022 | 16:26hComentários:
New data on COVID-19 lung transplants – Cedars-Sinai Medical Center
~7 Percent of Lung Transplants Due to COVID-19 Respiratory Failure – HealthDay